In December 2023, Boston Scientific Corporation (NYSE: BSX) initiated the AVANT GUARD trial to evaluate the safety and ...
The med-tech company with approximately 9,400 employees in Minnesota posted profit and sales that beat Wall Street’s ...
Boston Scientific is keeping the ball rolling in pulsed field ablation, posting 177% electrophysiology growth in the third ...
Boston Scientific reported third-quarter results that came in ahead of the consensus forecast, raising its 2024 guidance ...
Demand for the pulsed field ablation device drove the company’s electrophysiology sales up 177% in the third quarter compared ...
Despite a trial pause, Boston Scientific's impressive Q3 results and strategic expansions hint at a promising growth ...
TipRanks on MSN18h
Boston Scientific price target raised to $98 from $87 at Wells FargoWells Fargo raised the firm’s price target on Boston Scientific (BSX) to $98 from $87 and keeps an Overweight rating on the ...
William Plovanic, an analyst from Canaccord Genuity, maintained the Buy rating on Boston Scientific (BSX – Research Report). The ...
In this photo illustration, a Boston Scientific Corporation logo seen ... [+] displayed on a smartphone and pc screen in the ...
Analysis of Boston Scientific Corporation's Q3 results, future growth projections, and potential impact of regulatory ...
Mizuho raised the firm’s price target on Boston Scientific (BSX) to $110 from $100 and keeps an Outperform rating on the shares post the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback